J. Michael Murphy

Dr. J. Michael Murphy

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
ADAnamika Dutta
Anamika Dutta
FPFelipe Peña
Felipe Peña
JHJuliana M. Holcomb
Juliana M. Holcomb
LLLoreto Leiva
Loreto Leiva
ASAna María Squicciarini
Ana María Squicciarini
JMJ. Michael Murphy
J. Michael Murphy

1 January 2018 in Academic Pediatrics
Verified
Journal Article
Closed access
JMJ. Michael Murphy
J. Michael Murphy
TNTheresa Nguyen
Theresa Nguyen
CLCara Lucke
Cara Lucke
CCCindy Chiang
Cindy Chiang
NPNatalie Plasencia
Natalie Plasencia
MJMichael Jellinek
Michael Jellinek

1 December 1994 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
JMJ. Michael Murphy
J. Michael Murphy

1 December 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Jose A PiquerasJose A Piqueras
Jose A Piqueras
VVVerónica Vidal-Arenas
Verónica Vidal-Arenas
RFRaquel Falcó
Raquel Falcó
BMBeatriz Moreno-Amador
Beatriz Moreno-Amador
JMJuan C. Marzo
Juan C. Marzo
JMJ. Michael Murphy
J. Michael Murphy
Background: The short form, 17-item version of the Pediatric Symptom Checklist-Youth Self-Report (PSC-17-Y) is a validated measure that assesses psychosocial problems overall (OVR) and in 3 major psychopathological domains (internalizing, externalizing, and attention-deficit/hyperactivity disorder), taking 5-10 min to complete. Prior research has established sound psychometric properties of the PSC-17-Y for English speakers. Objective: This study extends psychometric evidence for the acceptability of the PSC-17-Y in a large sample of Spanish adolescents, providing proof of its reliability and structure, convergent and discriminant validity, and longitudinal and gender invariance. Methods: Data were collected on 5430 adolescents, aged 12-18 years, who filled out the PSC-17-Y twice during 2018-2019 (7-month interval). We calculated the Cronbach alpha and the McDonald omega coefficients to test reliability, the Pearson correlation for convergent (distress) and criterion validity (well-being, quality of life, and socioemotional skills), confirmatory factor analysis (CFA) for structure validity, and multigroup and longitudinal measurement invariance analysis for longitudinal and gender stability. Results: Within structural analysis for the PSC-17-Y, CFA supported a correlated 3-factor solution, which was also invariant longitudinally and across gender. All 3 subscales showed evidence of reliability, with coefficients near or above .70. Moreover, scores of PSC-17-Y subscales were positively related with convergent measures and negatively related with criterion measures. Normative data for the PSC-17-Y are presented in the form of percentiles (75th and 90th). Conclusions: This work provides the first evidence of the reliability and validity of the Spanish version of the PSC-17-Y administered over the internet to assess mental health problems among adolescents, maintaining the same domains as the long version.

1 May 2014 in Harvard Review of Psychiatry
Verified
Journal Article
Closed access
JMJ. Michael Murphy
J. Michael Murphy
AMAlyssa E. McCarthy
Alyssa E. McCarthy
LBLee Baer
Lee Baer
BZBonnie Zima
Bonnie Zima
MJMichael S. Jellinek
Michael S. Jellinek
The use of psychotropic medications for children and adolescents with attention and depression problems continues to generate both attention in the news media and controversy within the field. Given that the United Kingdom has recently issued guidelines for its national health service that differ substantially from those in the United States, the time is ripe to reexamine the evidence. The purpose of this article is to describe the UK's new "stepped care" guidelines for treating attention and depression problems in children and to compare them to the US guidelines issued by the American Academy of Pediatrics and the American Academy of Child and Adolescent Psychiatry. Our findings are that, despite many similarities, the UK guidelines are generally more conservative in their recommendations for medication use, especially for children experiencing only moderate impairment. Our article also compares prescription and diagnosis rates in the UK and the US, and reports evidence for lower rates of prescribing in the UK, despite some evidence that the rates of problems may not differ substantially. We conclude by noting that the existence of an alternative standard provides validation for clinicians or families who prefer to take a more conservative approach to medication use. The two different approaches to care also provide a valuable opportunity for research to determine whether the approaches result in different treatment outcomes.

3 February 2022 in Journal of Developmental & Behavioral Pediatrics
Verified
Journal Article
Closed access
JHJuliana M. Ba Holcomb
Juliana M. Ba Holcomb
ADAnamika Ba Dutta
Anamika Ba Dutta
PBPaul Ma Bergmann
Paul Ma Bergmann
ARAlexa Ba Riobueno-Naylor
Alexa Ba Riobueno-Naylor
HHHaregnesh Bs Haile
Haregnesh Bs Haile
JMJ. Michael Murphy
J. Michael Murphy
Objective: The objective of the study was to help pediatricians understand and respond to suicidal ideation (SI) in adolescents based on data from 2 widely used screening measures that assessed SI and other psychosocial vulnerabilities in a large, national sample. Methods: Adolescents (ages 11–17 years) completed the Patient Health Questionnaire Modified for Teenagers (PHQ-9M) using the Comprehensive Health and Decision Information System software before their well-child visits. Question 9 asks about past 2-week SI. Their parents filled out the Pediatric Symptom Checklist (PSC-17P), which screens for a broad range of psychosocial problems. Chi-square analyses and one-way analysis of variances assessed the relationship between SI and psychosocial problems. Results: Among 5411 adolescents, 266 (4.9%) reported SI at least several days in the past 2 weeks. Among adolescents with SI, 187 (70.3%) reported moderate to very severe depression on the PHQ-9M (≥10), 68.1% were at risk on at least 1 PSC-17P problem subscale, 59.7% on the PSC-17P internalizing scale, 42.9% on PSC-17P overall, 20.6% on PSC-17P externalizing, and 18.5% on PSC-17P attention. Within the subsample endorsing SI nearly all days, 35.7% had a former suicide attempt. Conclusion: The PHQ-9M identifies a clinically heterogeneous subset of approximately 5% of adolescents who report occasional to frequent SI. The PSC-17P corroborates their high degree of overall risk and offers additional information that can help pediatricians assess clinical severity and range of psychosocial problems. Given our limited knowledge of how to predict and prevent an individual adolescent's suicide, the focus of screening should be to identify and help the subset of patients with chronic psychosocial vulnerability of any type.